Crenezumab Biosimilar – Anti-APP Abeta42 and Abeta40 mAb – Research Grade

Reference:
Product nameCrenezumab Biosimilar - Anti-APP Abeta42 and Abeta40 mAb - Research Grade
SourceCAS 1095207-05-8
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsCrenezumab,MABT5102A,RG7412,APP Abeta42 and Abeta40,anti-APP Abeta42 and Abeta40
ReferencePX-TA1269
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody

Description of Crenezumab Biosimilar - Anti-APP Abeta42 and Abeta40 mAb - Research Grade

General information on Anti-APP Abeta42 and Abeta40[Homo sapiens] (Crenezumab) Monoclonal Antibody

Crenezumab has been investigated for the treatment of Alzheimer’s Disease.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Crenezumab Biosimilar – Anti-APP Abeta42 and Abeta40 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human APP (18-705) Recombinant Protein
Antigen

Human APP (18-705) Recombinant Protein

PX-P1059 221$
Human IgG4 Isotype Control antibody
Isotype Control

Human IgG4 Isotype Control antibody

PTX17887 189$
Stable Isotope Labelled Crenezumab Biosimilar – Anti-APP Abeta42 and Abeta40 mAb – Research Grade
SIL

Stable Isotope Labelled Crenezumab Biosimilar – Anti-APP Abeta42 and Abeta40 mAb – Research Grade

PX-TA1269-SIL 15750$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products